Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary Hypertension

StatusTerminated
PhasePhase 1/2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Why the trial stopped
Low subject accrual

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Terminatedv5
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
The goal of this study is to test the hypothesis that hydroxyurea is effective for the specific treatment of secondary pulmonary hypertension found on screening in children and young adults with sickle cell disease.
Trial Details
NCT Number NCT00350844
Lead Sponsor Ann & Robert H Lurie Children's Hospital of Chicago
Conditions
(from sponsor)		 Sickle Cell Disease, Pulmonary Hypertension
Related terms Anemia, Sickle Cell, Hypertension, Pulmonary
Enrollment 6 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov